EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, KNSA: Kiniksa Pharmaceuticals International Plc

08 Dec 25 15:25
LAST:

41.45

CHANGE:
 0.23		OPEN:
42.08		HIGH:
42.12		ASK:
0.00		VOLUME:
130.8K
CHG(%):
0.54		PREV:
41.68		LOW:
41.00		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
08 Dec 2542.0842.1241.0041.45130.8K
05 Dec 2541.1242.0040.3141.67339.5K
04 Dec 2540.3541.4839.7940.99331.0K
03 Dec 2540.3241.5539.6140.59231.8K
02 Dec 2540.8541.6740.0440.07235.5K
01 Dec 2542.3342.5340.6940.93352.8K
28 Nov 2542.5042.8942.0242.52147.7K
26 Nov 2542.9542.9842.0142.54311.9K
25 Nov 2541.3342.8541.0042.71479.1K
24 Nov 2541.7442.3640.7641.97614.0K

PROFILE

Name:Kiniksa Pharmaceuticals International Plc
About:Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-387, an investigational, that is in Phase 2/3 clinical trial for human immunoglobulin G2 monoclonal antibody that binds human interleukin-1 receptor 1, inhibiting IL-1a, IL-1ß-mediated signaling for the treatment of advance recurrent pericarditis by providing the added convenience of monthly subcutaneous dosing with a liquid formulation. Its preclinical products include KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody. The company was formerly known as Kiniksa Pharmaceuticals, Ltd and changed its name tpKiniksa Pharmaceuticals International, plc in June 2024. The company was incorporated in 2015 and is based in London, the United Kingdom.
Sector:Healthcare
Address:23 Old Bond Street, London, United Kingdom, WIS 4PZ
Website:https://www.kiniksa.com
CUSIP:G5269C101
CIK:0001730430
ISIN:BMG5269C1010
FIGI:BBG00KT2KFX7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:82.24 
Forward P/E:67.29 
PEG Ratio:-0.16 
Price to Sales:4.69 
Price to Book:5.21 
Profit Margin:0.06 
Operating Margin:0.13 
Return on Assets:0.04 
Return on Equity:0.07 
EPS Ratio:0.05 
Revenue:597.97M 
EBITDA:39.64M 
Shares:43.47M 
Market Cap:1.802B 

TECHNICAL INDICATORS

MA5:40.941.3%
MA10:41.540.2%
MA20:41.230.5%
MA50:39.544.8%
MA100:36.4113.8%
MA200:30.7135.0%
STO9:44.67
STO14:44.67
RSI14:49.80
WPR14:-50.76
MTM14:0.09
ROC14:0.00 
ATR:1.55 
Week High:42.532.6%
Week Low:39.614.6%
Month High:42.983.7%
Month Low:38.5735.0%
Year High:42.983.7%
Year Low:17.82132.6%
Volatility:28.77